KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer
Journal of Radiation Research · 2023
DOI: 10.1093/jrr/rrac107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, 2023. Verfasst von Yan Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, 730000, P. R. China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Gansu Provincial National Science Foundation for Distinguished Young Scholars, Zhejiang Provincial Nature Science Foundation of China.
Abstract (Originalsprache)
Chromatin-modifying enzymes are commonly altered in cancers, but the molecular mechanism by which they regulate cancers remains poorly understood. Herein, we demonstrated that Lysine acetyltransferase 7 (KAT7) was upregulated in breast cancer. KAT7 expression negatively correlated with the survival of breast cancer patients, and KAT7 silencing suppressed breast cancer radioresistance in vitro. Mechanistically, KAT7 activated Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) transcription, leading to enhanced PI3K/AKT signaling and radioresistance. Overexpression of AKT or PIK3CA restored radioresistance suppression induced by KAT7 inhibition. Moreover, overexpression of KAT7, but not KAT7 acetyltransferase activity-deficient mutants promoted AKT phosphorylation at the Ser473 site, PIK3CA expression and radioresistance suppression due to KAT7 inhibition. In conclusion, KAT7 has huge prospects for clinical application as a new target for predicting radioresistance in breast cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, 730000, P. R. China.
- Department of Radiation Oncology, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, Gansu, 730000, P. R. China.
- Department of Endocrinology, Yiyang Central Hospital, Yiyang, Hunan, 413000, P. R. China.
- Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, 550002, P.R. China.
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu, 730000, P.R. China.
- Lanzhou Heavy Ion Hospital, Lanzhou, Gansu, 730000, P.R. China.
Förderung
- National Natural Science Foundation of China
- Gansu Provincial National Science Foundation for Distinguished Young Scholars
- Zhejiang Provincial Nature Science Foundation of China
- The First Hospital of Lanzhou University Foundation
Zitieren
APA
Ma, Y., Chen, X., Ding, T., Zhang, H., Zhang, Q., Dai, H., Zhang, H., Tang, J., & Wang, X. (2023). KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrac107
Vancouver
Ma Y, Chen X, Ding T, Zhang H, Zhang Q, Dai H, et al. KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer. Journal of Radiation Research. 2023. doi:10.1093/jrr/rrac107
BibTeX
@article{Ma2023,
author = {Ma, Yan and Chen, Xiaohua and Ding, Ting and Zhang, Hanqun and Zhang, Qiuning and Dai, Huanyu and Zhang, Haibo and Tang, Jianming and Wang, Xiaohu},
title = {KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer},
journal = {Journal of Radiation Research},
year = {2023},
doi = {10.1093/jrr/rrac107}
}
EUVIMED